KIM
REVBU

Karpus Investment Management’s Revelation Biosciences, Inc. Unit REVBU Stock Holding History

Karpus Investment Management’s Portfolio REVBU Stock Details REVBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27,200
Closed -$294K – 336
2020
Q4 		$294K Buy
+27,200
New +$276K 0.01% 209

Other funds holding REVBU

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Karpus Investment Management's REVBU Position: Q1 2021 in Review

Karpus Investment Management sold out of Revelation Biosciences, Inc. Unit (REVBU) in Q1 2021, closing a stake of 27,200 shares — an estimated $294K sold.

Karpus Investment Management first reported a position in REVBU in Q4 2020 and held it in 1 quarter. The position peaked at $294K in Q4 2020. 4 funds tracked by Wall St. Rank hold REVBU as of Q1 2021.

  • Karpus Investment Management reported no remaining Revelation Biosciences, Inc. Unit position as of Q1 2021 after selling out during the quarter.
  • Karpus Investment Management sold 27,200 Revelation Biosciences, Inc. Unit shares in Q1 2021, an estimated $294K.
  • Karpus Investment Management first reported a position in Revelation Biosciences, Inc. Unit in Q4 2020 and held it in 1 quarter.
  • Karpus Investment Management's Revelation Biosciences, Inc. Unit position peaked at $294K in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Revelation Biosciences, Inc. Unit as of Q1 2021.

Based on Karpus Investment Management's 13F filing for Q1 2021, filed 17 May 2021.